UK Markets closed

SENS Jul 2022 5.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
0.5500+0.1200 (+27.91%)
As of 03:48PM EDT. Market open.
Full screen
Previous close0.4300
Open0.5900
Bid0.2400
Ask0.8600
Strike5.00
Expiry date2022-07-15
Day's range0.5100 - 0.5900
Contract rangeN/A
Volume436
Open interest288
  • Business Wire

    Senseonics Announces CE Mark Approval of the Eversense E3 Continuous Glucose Monitoring System

    GERMANTOWN, Md., June 16, 2022--Senseonics Holdings, Inc. (NYSE American: SENS) a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced that it has received CE Mark approval for the next-generation Eversense® E3 CGM System, the longest-lasting system available, with exceptional accuracy. The CE Mark approval confirms that the Eversense E3 meets the requirements of the

  • Business Wire

    Senseonics to Participate in the Jefferies Healthcare Conference

    GERMANTOWN, Md., May 26, 2022--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced plans to participate in the upcoming Jefferies Healthcare Conference in New York, NY.

  • Business Wire

    Senseonics to Participate in the H.C. Wainwright Global Investment Conference

    GERMANTOWN, Md., May 16, 2022--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced plans to participate in the upcoming hybrid H.C. Wainwright Global Investment Conference.